Sophia Genetics SA
SOPH3.520USD
+0.360+11.39%
시장 운영 시간 （ET）시세는 15분 지연됩니다
235.21M시가총액
손실P/E TTM
자세한 내용은 Sophia Genetics SA 회사
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.
회사 정보
종목 코드 SOPH
회사 이름Sophia Genetics SA
상장일Jul 23, 2021
CEODr. Jurgi Camblong, Ph.D.
직원 수423
유형Ordinary Share
회계 연도 종료Jul 23
주소La Piece 12
도시ROLLE
증권 거래소NASDAQ Global Select Consolidated
국가Switzerland
우편 번호1180
전화41216941060
웹사이트https://www.sophiagenetics.com/
종목 코드 SOPH
상장일Jul 23, 2021
CEODr. Jurgi Camblong, Ph.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+7.89%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+12.21%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-4.26%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+25.98%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+79.72%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+108.22%
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
60.38K
+51.32%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
39.60K
-5.14%
Mr. Milton G. Silva-Craig, J.D.
Mr. Milton G. Silva-Craig, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+7.89%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+12.21%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-4.26%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+25.98%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+79.72%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+108.22%
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
데이터 없음
지역별USD
이름
수익
비율
Rest of EMEA
5.51M
31.00%
France
2.61M
14.70%
Italy
2.53M
14.23%
United States
2.48M
13.95%
Spain
1.42M
7.97%
Other
3.23M
18.15%
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Wed, Jul 23
마지막 업데이트: Wed, Jul 23
주주
주주 유형
주주
주주
비율
Alychlo NV
10.46%
Generation Investment Management LLP
10.16%
aMoon Fund
8.25%
UBS Asset Management (Switzerland)
6.79%
Akre Capital Management, LLC
5.57%
Other
58.78%
주주
주주
비율
Alychlo NV
10.46%
Generation Investment Management LLP
10.16%
aMoon Fund
8.25%
UBS Asset Management (Switzerland)
6.79%
Akre Capital Management, LLC
5.57%
Other
58.78%
주주 유형
주주
비율
Investment Advisor
17.54%
Investment Advisor/Hedge Fund
16.07%
Venture Capital
13.28%
Family Office
10.52%
Individual Investor
6.53%
Hedge Fund
0.91%
Bank and Trust
0.46%
Pension Fund
0.14%
Other
34.55%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
89
36.68M
54.88%
-257.44K
2025Q1
93
36.63M
54.82%
-389.48K
2024Q4
93
32.50M
49.36%
-965.83K
2024Q3
91
34.60M
52.08%
+657.87K
2024Q2
92
32.44M
48.93%
+1.33M
2024Q1
93
31.91M
48.51%
+375.11K
2023Q4
91
30.61M
46.76%
-676.23K
2023Q3
91
30.34M
46.61%
-4.34M
2023Q2
90
31.34M
48.19%
-3.70M
2023Q1
86
30.07M
46.79%
+1.58M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Alychlo NV
6.99M
10.46%
--
--
Feb 15, 2025
Generation Investment Management LLP
6.79M
10.16%
--
--
Mar 31, 2025
aMoon Fund
5.51M
8.25%
+577.36K
+11.70%
Feb 15, 2025
UBS Asset Management (Switzerland)
4.54M
6.79%
+2.34M
+106.14%
Mar 31, 2025
Akre Capital Management, LLC
3.72M
5.57%
+1.48M
+66.22%
Jun 20, 2025
Balderton Capital (UK) LLP
3.36M
5.03%
--
--
Feb 15, 2025
UBS Asset Management (Americas) LLC
3.10M
4.64%
+3.10M
--
Mar 31, 2025
Camblong (Jurgi)
2.65M
3.97%
+194.16K
+7.89%
Feb 15, 2025
Banque Pictet & Cie S.A.
2.21M
3.31%
-32.20K
-1.44%
Mar 31, 2025
Principal Global Investors (Equity)
1.39M
2.07%
-43.33K
-3.03%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Health Innovation Active ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Health Innovation Active ETF
비율0%
Fidelity Nasdaq Composite Index ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
